Methylene blue for CPB [11]

Anesthesia and Analgesia

Volumn 104, Issue 5, 2007, Pages 1296-

  Valchanov, K ^a   Falter, F ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE;

CARDIOPULMONARY BYPASS; CONTINUOUS INFUSION; HUMAN; HYPOTENSION; LETTER; MEAN ARTERIAL PRESSURE; MORBIDITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL MORTALITY; METHODOLOGY; NOTE; TIME;

CARDIOPULMONARY BYPASS; HUMANS; HYPOTENSION; METHYLENE BLUE; TIME FACTORS;

EID: 34247498080     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000260369.82560.10     Document Type: Letter

References (4)

1. Maslow AD, Stearns G, Parag B, et al. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg 2006;103:2-8.
2. Reich DL, Bodian CA, Krol M, et al. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg 1999;89:814-22.
3. Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after non-cardiac surgery. Anesth Analg 2005;100:4-10.
4. Kirov MY, Evgenov OV, Evgenova NV, et al. Infusion of methylene blue in human septic shock: a pilot, randomised, controlled study. Crit Care Med 2001;29:1860-7.